Target intelligence / Profile preview

40S ribosomal protein S16 (RPS16)

Target
RPS16
Molecular classification
Ribosomal protein, Structural constituent of ribosome, S9P family of ribosomal proteins
01

Overview

40S ribosomal protein S16 (RPS16) is a protein component of the small 40S ribosomal subunit in eukaryotic cells, encoded by the RPS16 gene. It is a member of the S9P family of ribosomal proteins and resides in the cytoplasm[1][2][3][4]. RPS16 binds specifically and with high affinity to regions of the 18S rRNA, promoting proper rRNA folding and ribosome assembly. In addition to its structural role, RPS16 participates in an autoregulatory feedback mechanism that controls its own pre-mRNA splicing, thus fine-tuning its synthesis according to cellular biogenesis needs. RPS16 is regulated by microRNAs (such as miR-7641 and let-7 family), which are involved in cellular stress responses, including antiviral activity and sensitivity to chemotherapy in cancer cells. Although RPS16 is implicated as a marker in certain diseases (notably Diamond-Blackfan anemia and some cancers), it is not itself a canonical drug target, but its regulatory mechanisms may be exploited for therapeutic benefit[1][2][3][4][5].

Other names
Small ribosomal subunit protein uS940S ribosomal protein S16S16uS9RS16_HUMANRPS16
02

Mechanism of action

Not applicable; no drugs directly target RPS16. However, targeting microRNAs (e.g., let-7 family, miR-7641) that regulate RPS16 expression may alter cellular responses in cancer or viral infection.

03

Biological functions

Protein synthesis (translation)Ribosome biogenesis, assembly, and functionRNA binding and structural constituent of ribosomeAutoregulatory feedback mechanism controlling its own expressionRegulation via microRNAs (let-7 family, miR-7641), which impact cellular stress responses and antiviral activity
04

Disease associations

Diamond-Blackfan anemiaCancer (microRNAs targeting RPS16 influence cancer cell sensitivity to chemotherapy)Viral infection/antiviral response (influenza A virus, via interferon modulation)Other ribosomopathies (generalized defects in ribosomal function)
05

Safety considerations

Not directly applicable; RPS16 is essential for cell viability, so manipulations could disrupt fundamental cellular processesSafety concerns would be limited to indirect interventions (e.g., microRNA-based therapies), likely involving off-target ribosomal defects or generalized cytotoxicity
06

Interacting drugs

None directly known.
07

Biomarkers

Expression of RPS16 as a biomarker for Diamond-Blackfan anemiaDownregulation by miR-7641 and let-7 family in cancer cells and viral infection as a possible predictive biomarker of disease progression or treatment response

Beyond the preview

Go deeper on 40S ribosomal protein S16 (RPS16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 40S ribosomal protein S16 (RPS16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call